Cementless Total Hip Arthoplasties in Gaucher Disease: Long-Term Follow-Up
Ehud Lebel, MD, Deborah Elstein, PhD, Ari Zimran, MD, and Menachem Itzchaki, MD
Dr. Lebel is Senior Orthopedist, Department of Orthopaedic Surgery, Dr. Elstein is Coordinator of Clinical Research, Dr. Zimran is Director, Gaucher Clinic, and Dr. Itzchaki is Chief of Orthopaedics, Department of Orthopaedic Surgery, Shaare Zedek Medical Center, Jerusalem, Israel.
We retrospectively assessed the clinical and radiologic outcomes of 15 primary cementless total hip arthroplasties performed in 12 young adults with type I Gaucher disease. Mean Harris Hip Score was 86.9 points; patient satisfaction was high. There were no serious postoperative complications. Weight-bearing ambulation was immediate. Only 3 hips required revisions. In cases of Gaucher disease, cementless hip arthroplasties are safe and effective. Because patients with chronic metabolic disorders differ from healthy patients with traumatic fractures, the results reported in this article may have implications for nontraumatic hip arthroplasty.